{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T03:14:35Z","timestamp":1782789275354,"version":"3.54.5"},"reference-count":51,"publisher":"Elsevier BV","issue":"1-3","license":[{"start":{"date-parts":[[2013,3,1]],"date-time":"2013-03-01T00:00:00Z","timestamp":1362096000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Forensic Science International"],"published-print":{"date-parts":[[2013,3]]},"DOI":"10.1016\/j.forsciint.2013.01.038","type":"journal-article","created":{"date-parts":[[2013,2,18]],"date-time":"2013-02-18T12:16:29Z","timestamp":1361189789000},"page":"254-260","source":"Crossref","is-referenced-by-count":32,"title":["Postmortem blood and tissue concentrations of R- and S-enantiomers of methadone and its metabolite EDDP"],"prefix":"10.1016","volume":"226","author":[{"given":"Ricarda","family":"Jantos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gisela","family":"Skopp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.forsciint.2013.01.038_bib0005","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/S0379-0738(03)00057-4","article-title":"Methadone substitution: medicolegal problems in Germany","volume":"133","author":"Musshoff","year":"2003","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.forsciint.2013.01.038_bib0010","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1136\/jcp.53.4.277","article-title":"Methadone deaths: a toxicological analysis","volume":"53","author":"Milroy","year":"2000","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/j.forsciint.2013.01.038_bib0015","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/j.1742-7843.2010.00628.x","article-title":"Stereo-selective metabolism of methadone by human liver microsomes and cDNA-expressed cytochrome P450s: a reconciliation","volume":"108","author":"Chang","year":"2011","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"10.1016\/j.forsciint.2013.01.038_bib0020","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1097\/ALN.0b013e3181642938","article-title":"Role of CYP2B6 in stereoselective human methadone metabolism","volume":"108","author":"Totah","year":"2008","journal-title":"Anesthesiology"},{"key":"10.1016\/j.forsciint.2013.01.038_bib0025","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1093\/jat\/22.6.526","article-title":"Detection of methadone, methadone metabolites, and other illicit drugs of abuse in hair of methadone-treatment subjects","volume":"22","author":"Goldberger","year":"1998","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.forsciint.2013.01.038_bib0030","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/0378-4347(91)80216-Y","article-title":"Chiral analysis of methadone in plasma by high-performance liquid chromatography","volume":"570","author":"Beck","year":"1991","journal-title":"J. Chromatogr."},{"key":"10.1016\/j.forsciint.2013.01.038_bib0035","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0376-8716(02)00320-4","article-title":"Cytochrome P4503A4 metabolic activity, methadone blood concentrations, and methadone doses","volume":"69","author":"Shinderman","year":"2003","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.forsciint.2013.01.038_bib0040","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.clpt.2004.05.003","article-title":"Role of hepatic and intestinal cytochrome P450 3A and 2B6 in the metabolism, disposition, and miotic effects of methadone","volume":"76","author":"Kharasch","year":"2004","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.forsciint.2013.01.038_bib0045","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1097\/ALN.0b013e3181986a9a","article-title":"Methadone pharmacokinetics are independent of cytochrome P4503A (CYP3A) activity and gastrointestinal drug transport: insights fro methadone interactions with ritonavir\/indinavir","volume":"110","author":"Kharasch","year":"2009","journal-title":"Anesthesiology"},{"key":"10.1016\/j.forsciint.2013.01.038_bib0050","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1038\/clpt.2008.104","article-title":"Mechanism of ritonavir changes in methadone pharmacokinetics and pharmacodynamics: I. evidence against CYP3A mediation of methadone clearance","volume":"84","author":"Kharasch","year":"2008","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.forsciint.2013.01.038_bib0055","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.drugalcdep.2008.12.009","article-title":"Methadone metabolism and clearance are induced by nelfinavir despite of cytochrome P4503A (CYP3A) activity","volume":"101","author":"Kharasch","year":"2009","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.forsciint.2013.01.038_bib0060","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.2165\/00003088-200241140-00003","article-title":"Interindividual variability of the clinical pharmacokincetics of methadone","volume":"41","author":"Eap","year":"2002","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.forsciint.2013.01.038_bib0065","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1046\/j.1360-0443.2002.00179.x","article-title":"An increase in overdose mortality during the first 2 weeks after entering or re-entering methadone treatment in Amsterdam","volume":"97","author":"Buster","year":"2002","journal-title":"Addiction"},{"key":"10.1016\/j.forsciint.2013.01.038_bib0070","series-title":"Disposition of Toxic Drugs and Chemicals in Man","author":"Baselt","year":"2011"},{"key":"10.1016\/j.forsciint.2013.01.038_bib0075","first-page":"185","article-title":"Anhang B zur Richtlinie der GTFCh zur Qualit\u00e4tssicherung bei forensisch-toxikologischen Untersuchungen. Anforderungen an die Validierung von Analysenmethoden","volume":"76","author":"Peters","year":"2009","journal-title":"Toxichem Krimtech"},{"key":"10.1016\/j.forsciint.2013.01.038_bib0080","doi-asserted-by":"crossref","first-page":"3019","DOI":"10.1021\/ac020361s","article-title":"Strategies for the assessment of matrix effect in quantitative bioanalytical methods based on HPLC\u2013MS\/MS","volume":"75","author":"Matuszewski","year":"2003","journal-title":"Anal. Chem."},{"key":"10.1016\/j.forsciint.2013.01.038_bib0085","doi-asserted-by":"crossref","first-page":"E109","DOI":"10.1208\/aapsj0901011","article-title":"Key elements of bioanalytical method validation for small molecules","volume":"9","author":"Bansal","year":"2007","journal-title":"AAPS"},{"key":"10.1016\/j.forsciint.2013.01.038_bib0090","unstructured":"ICH harmonised tripartite guideline: validation of analytical procedures: text and methodology Q2(R1), International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use, 2005."},{"key":"10.1016\/j.forsciint.2013.01.038_bib0095","unstructured":"FDA guidance for industry: bioanalytical method validation, U.S. Department of Health and Human Services, Center for Drug Evaluation and Research, Food and Drug Administration, 2001."},{"key":"10.1016\/j.forsciint.2013.01.038_bib0100","unstructured":"TIAFT, TIAFT reference blood level list of therapeutic and toxic substances, 2004."},{"key":"10.1016\/j.forsciint.2013.01.038_bib0105","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.clpt.2004.10.013","article-title":"Interpretation of opioid levels: comparison of levels during chronic pain therapy to levels from forensic autopsies","volume":"77","author":"Jung","year":"2005","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.forsciint.2013.01.038_bib0110","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1111\/j.1556-4029.2009.01278.x","article-title":"Postmortem blood concentrations of R- and S-enantiomers of methadone and EDDP in drug users: influence of co-medication and P-glycoprotein genotype","volume":"55","author":"Buchard","year":"2010","journal-title":"J. Forensic Sci."},{"key":"10.1016\/j.forsciint.2013.01.038_bib0115","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.forsciint.2005.04.014","article-title":"Fatal methadone concentration in an infant","volume":"153","author":"Couper","year":"2005","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.forsciint.2013.01.038_bib0120","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/BF02116825","article-title":"Methadone in autopsy cases","volume":"73","author":"Norheim","year":"1973","journal-title":"Rechtsmedizin"},{"key":"10.1016\/j.forsciint.2013.01.038_bib0125","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1111\/j.1556-4029.2007.00565.x","article-title":"Methadone toxicity fatalities: a review of medical examiner cases in a large metropolitan area","volume":"52","author":"Shields","year":"2007","journal-title":"J. Forensic Sci."},{"key":"10.1016\/j.forsciint.2013.01.038_bib0130","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1046\/j.1365-2125.2000.00272.x","article-title":"Steady-state pharmacokinetics of (R)- and (S)-methadone in methadone maintenance patients","volume":"50","author":"Foster","year":"2000","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.forsciint.2013.01.038_bib0135","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/BF00194951","article-title":"Pharmacokinetics of methadone and its primary metabolite in 20 opiate addicts","volume":"48","author":"de Vos","year":"1995","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.forsciint.2013.01.038_bib0140","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/s12024-012-9341-2","article-title":"The effect of the postmortem interval on the redistribution of drugs: a comparison of mortuary admission and autopsy blood specimens","volume":"8","author":"Gerostamoulos","year":"2012","journal-title":"Forensic Sci. Med. Pathol."},{"key":"10.1016\/j.forsciint.2013.01.038_bib0145","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1080\/0959523021000023171","article-title":"Methadone dose and post-mortem blood concentration","volume":"21","author":"Caplehorn","year":"2002","journal-title":"Drug Alcohol Rev."},{"key":"10.1016\/j.forsciint.2013.01.038_bib0150","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1097\/00000433-199506000-00002","article-title":"Site dependence of postmortem blood methadone concentrations","volume":"16","author":"Levine","year":"1995","journal-title":"Am. J. Forensic Med. Pathol."},{"key":"10.1016\/j.forsciint.2013.01.038_bib0155","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1345\/aph.1G277","article-title":"QT-prolongation and syncope with methadone, doxepin, and a \u03b2-blocker","volume":"39","author":"Rademacher","year":"2005","journal-title":"Ann. Pharmacother."},{"key":"10.1016\/j.forsciint.2013.01.038_bib0160","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1097\/00006842-197503000-00006","article-title":"A review of the cardiovascular effects and toxicity of tricyclic antidepressants","volume":"37","author":"Jefferson","year":"1975","journal-title":"Psychosom. Med."},{"key":"10.1016\/j.forsciint.2013.01.038_bib0165","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1055\/s-2007-1000726","article-title":"Neurotoxicity of benzodiazepines","volume":"59","author":"Karkos","year":"1991","journal-title":"Fortschr. Neurol. Psychiat."},{"key":"10.1016\/j.forsciint.2013.01.038_bib0170","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1111\/j.1467-842X.2002.tb00185.x","article-title":"Fatal methadone toxicity: signs and circumstances, and the role of benzodiazepines","volume":"26","author":"Caplehorn","year":"2002","journal-title":"Aust. N. Z. J. Public Health"},{"key":"10.1016\/j.forsciint.2013.01.038_bib0175","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.pbb.2011.10.023","article-title":"Subjective psychomotor and physiological effects of pregabalin alone and in combination with oxycodone in healthy volunteers","volume":"100","author":"Zacny","year":"2012","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.forsciint.2013.01.038_bib0180","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1111\/j.1526-4637.2008.00492.x","article-title":"Gabapentin toxicity in renal failure: the importance of dose adjustment","volume":"10","author":"Miller","year":"2009","journal-title":"Pain Med."},{"key":"10.1016\/j.forsciint.2013.01.038_bib0185","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1007\/s001940000067","article-title":"Der stereoselektive Nachweis von l- und d-Methadon in Blutproben von lebenden und verstorbenen Drogenabh\u00e4ngigen","volume":"10","author":"Drasch","year":"2000","journal-title":"Rechtsmedizin"},{"key":"10.1016\/j.forsciint.2013.01.038_bib0190","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1093\/jat\/32.7.499","article-title":"Chiral analysis of methadone and its main metabolite EDDP in postmortem blood by liquid chromatography\u2013mass spectrometry","volume":"32","author":"Johansen","year":"2008","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.forsciint.2013.01.038_bib0195","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.forsciint.2008.04.019","article-title":"Dominance of pre-analytical over analytical variation for measurement of methadone and its main metabolite in postmortem femoral blood","volume":"179","author":"Linnet","year":"2008","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.forsciint.2013.01.038_bib0200","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1081\/CLT-120018270","article-title":"Post-mortem toxicology: what the dead can and cannot tell us","volume":"41","author":"Leikin","year":"2003","journal-title":"J. Toxicol. Clin. Toxicol."},{"key":"10.1016\/j.forsciint.2013.01.038_bib0205","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.forsciint.2004.02.013","article-title":"Postmortem toxicology of drugs of abuse","volume":"142","author":"Drummer","year":"2004","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.forsciint.2013.01.038_bib0210","series-title":"Wiley Encyclopedia of Forensic Science","first-page":"1","article-title":"Postmortem toxicology: artifacts","author":"Skopp","year":"2009"},{"key":"10.1016\/j.forsciint.2013.01.038_bib0220","doi-asserted-by":"crossref","DOI":"10.1016\/j.forsciint.2004.02.017","article-title":"Fatal blood and tissue concentrations of more than 200 drugs","volume":"142","author":"Musshoff","year":"2004","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.forsciint.2013.01.038_bib0225","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1093\/jat\/bks057","article-title":"Chiral analysis of methadone and its main metabolite, EDDP, in postmortem brain and blood by automated SPE and liquid chromatography\u2013mass spectrometry","volume":"36","author":"Holm","year":"2012","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.forsciint.2013.01.038_bib0230","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1093\/toxsci\/kfp097","article-title":"Chiral toxicology: it's the same thing only different","volume":"110","author":"Smith","year":"2009","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.forsciint.2013.01.038_bib0235","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1111\/j.1365-2125.2004.02221.x","article-title":"Subjective and physiological responses among racemic-methadone maintenance patients in relation to relative (S)- vs. (R)-methadone exposure","volume":"58","author":"Mitchell","year":"2004","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.forsciint.2013.01.038_bib0240","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1002\/bmc.1363","article-title":"Development of a method to measure methadone enantiomers and its metabolites without enantiomer standard compounds for the plasma of methadone maintenance patients","volume":"24","author":"Wang","year":"2010","journal-title":"Biomed. Chromatogr."},{"key":"10.1016\/j.forsciint.2013.01.038_bib0245","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1520\/JFS2002424","article-title":"Methadone-related deaths in Hennepin County, Minnesota: 1992\u20132002","volume":"48","author":"Gagajewski","year":"2003","journal-title":"J. Forensic Sci."},{"key":"10.1016\/j.forsciint.2013.01.038_bib0250","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1097\/00007691-199606000-00001","article-title":"Stereoselective pharmacokinetics of methadone in chronic pain patients","volume":"18","author":"Kristensen","year":"1996","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.forsciint.2013.01.038_bib0255","first-page":"644","article-title":"Illicit methadone injecting during methadone maintenance treatment in a specialised out-patient clinic","volume":"135","author":"Waldvogel","year":"2005","journal-title":"Swiss Med. Wkly."},{"key":"10.1016\/j.forsciint.2013.01.038_bib0260","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/j.1465-3362.2009.00080.x","article-title":"Drug injection in patients in New Zealand methadone maintenance treatment programs: an anonymous survey","volume":"29","author":"Judson","year":"2010","journal-title":"Drug Alcohol Rev."}],"container-title":["Forensic Science International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0379073813000595?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0379073813000595?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,18]],"date-time":"2018-10-18T12:30:50Z","timestamp":1539865850000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0379073813000595"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3]]},"references-count":51,"journal-issue":{"issue":"1-3","published-print":{"date-parts":[[2013,3]]}},"alternative-id":["S0379073813000595"],"URL":"https:\/\/doi.org\/10.1016\/j.forsciint.2013.01.038","relation":{},"ISSN":["0379-0738"],"issn-type":[{"value":"0379-0738","type":"print"}],"subject":[],"published":{"date-parts":[[2013,3]]}}}